Population pharmacokinetics and model-informed precision dosing of lamivudine in Chinese HIV-infected patients with mild and moderate impaired renal function-Reference-Cited by-同舟云学术

Population pharmacokinetics and model-informed precision dosing of lamivudine in Chinese HIV-infected patients with mild and moderate impaired renal function

Published:2022-05-04 Issue:5 Volume:15 Page:647-655
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Wen Haini¹²^ORCID,Yin Lin¹,Wang Jiangrong¹,Zhang Lin¹,Sun Tao¹,Xu Feng³,Zhang Minxin⁴,Liu Li¹,Zhang Renfang¹,Liu Xiaoqian¹,Meng Xianmin¹^ORCID,Xing Yaru¹,Lu Hongzhou¹^ORCID,Jiao Zheng²^ORCID,Zhang Lijun¹

Affiliation:

1. Department of Clinical Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

2. Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, P.R. China

3. Department of Pharmacy, The Second Affiliated Hospital of Soochow University, SuZhou, Jiangsu, China

4. Department of Pharmacy, The 900th Hospital of Joint Logistic Support Force of PLA, Fuzhou, Fujian, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2078306

Reference32 articles.

1. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. [Aug 16th, 2021]

3. Pharmacokinetics of nucleoside/nucleotide reverse transcriptase inhibitors for the treatment and prevention of HIV infection

4. Clinical Pharmacokinetics of Lamivudine